Literature DB >> 172533

Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.

G Sigurdsson, A Nicoll, B Lewis.   

Abstract

The interrelationship between apolipoprotein B in very low density lipoprotein (VLDL-B) and in low density lipoprotein (LDL-B) was studied in seven normal and hyperlipidemic men and women, with purified radioiodinated VLDL. The time-course of the appearance of radioactivity in LDL was followed. As the specific activity curves intersected at the masimal height of the LDL-B curve, it was inferred that all or most LDL-B peptide is derived from VLDL-B peptide. This transfer was further quantitated in seven normotriglyceridemic subjects by simultaneous i.v. injection of purified 131I-VLDL and 125I-LDL. By a deconvolution method, a quantitative description of the rate of entry of 131Ivldl-b into 131I-LDL-B was derived by analysis of 131I-LDL-B and 125I-ldl-b radioactivity in plasma. The results indicate that approximately 90% of VLDL-B mass is converted into LDL-B in subjects with normal serum triglyceride concentrations. The synthetic rates of VLDL-B and LDL-B peptide were simultaneously measured in six normal subjects, and two patients with heterozygous familial hypercholesterolemia (type IIa). The turnover rates for VLDL-B and LDL-B peptide were similar in these subjects. The findings in the three parts of this study were consistent with the view that most if not all VLDL-B is converted into LDL-B peptide, and most if not all LDL-B is derived from VLDL-B peptide in normotriglyceridemic subjects.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172533      PMCID: PMC333126          DOI: 10.1172/JCI108229

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Blood volume.

Authors:  M I GREGERSEN; R A RAWSON
Journal:  Physiol Rev       Date:  1959-04       Impact factor: 37.312

2.  STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM.

Authors:  A GUSTAFSON; P ALAUPOVIC; R H FURMAN
Journal:  Biochemistry       Date:  1965-03       Impact factor: 3.162

3.  The design and analysis of isotope experiments.

Authors:  D B ZILVERSMIT
Journal:  Am J Med       Date:  1960-11       Impact factor: 4.965

4.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

5.  Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins.

Authors:  D GITLIN; D G CORNWELL; D NAKASATO; J L ONCLEY; W L HUGHES; C A JANEWAY
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

6.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

7.  Blood lipids and human atherosclerosis. II. The influence of heparin upon lipoprotein metabolism.

Authors:  D M GRAHAM; T P LYON; J W GOFMAN; H B JONES; A YANKLEY; J SIMONTON; S WHITE
Journal:  Circulation       Date:  1951-11       Impact factor: 29.690

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels.

Authors:  B Lewis; A Chait; I D Wootton; C M Oakley; D M Krikler; G Sigurdsson; A February; B Maurer; J Birkhead
Journal:  Lancet       Date:  1974-02-02       Impact factor: 79.321

10.  A rapid, sensitive, and specific method for the determination of protein in dilute solution.

Authors:  W Schaffner; C Weissmann
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

View more
  42 in total

Review 1.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

Authors:  N E Miller
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

2.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

3.  Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

Authors:  J S Cohn; D A Wagner; S D Cohn; J S Millar; E J Schaefer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  The metabolic modification of low-density lipoproteins in normal and hypercholesterolaemic guinea pigs.

Authors:  P K Weech; G L Mills
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

5.  Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.

Authors:  P R Turner; N E Miller; C Cortese; W Hazzard; J Coltart; B Lewis
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

6.  Studies on the production of low density lipoproteins by perfused livers from nonhuman primates. Effect of dietary cholesterol.

Authors:  F L Johnson; R W St Clair; L L Rudel
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

8.  Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.

Authors:  P Mistry; N E Miller; M Laker; W R Hazzard; B Lewis
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

9.  Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.

Authors:  E A Nikkilä; R Ylikahri; J K Huttunen
Journal:  Proc R Soc Med       Date:  1976

10.  Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.

Authors:  Y A Kesaniemi; S M Grundy
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.